Stock IBX IMAGION BIOSYSTEMS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Imagion Biosystems Limited

Equities

IBX

AU000000IBX6

Advanced Medical Equipment & Technology

Delayed Australian S.E.
Other stock markets
 12:50:03 2024-03-28 am EDT 		5-day change 1st Jan Change
0.074 AUD -9.76% Intraday chart for Imagion Biosystems Limited -.--% -79.15%
Feb. 29 Imagion Biosystems Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Jan. 15 Imagion Biosystems CEO Resigns MT

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 22.41 9.682 12.78 144.8 85.2 26.91
Enterprise Value (EV) 1 15.62 5.369 10.26 132.2 71.85 27.07
P/E ratio -2.17 x -0.79 x -2.49 x -20.2 x -12.7 x -2.67 x
Yield - - - - - -
Capitalization / Revenue 66.1 x 26.1 x 5.13 x 53.7 x 29.8 x 8.76 x
EV / Revenue 46.1 x 14.5 x 4.12 x 49 x 25.2 x 8.81 x
EV / EBITDA -2.35 x -0.63 x -3.13 x -25.5 x -12.2 x -2.85 x
EV / FCF -3.07 x -1.34 x -3.92 x -42.9 x -23.9 x -5.3 x
FCF Yield -32.6% -74.9% -25.5% -2.33% -4.18% -18.9%
Price to Book 3.22 x 2.5 x 4.3 x 11.2 x 6.4 x 5.75 x
Nbr of stocks (in thousands) 5,094 8,069 12,782 24,959 28,025 28,033
Reference price 2 4.400 1.200 1.000 5.800 3.040 0.9600
Announcement Date 2/28/18 3/29/19 3/31/20 2/25/21 2/24/22 2/27/23
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 0.3391 0.3715 2.49 2.697 2.856 3.071
EBITDA 1 -6.652 -8.563 -3.272 -5.191 -5.896 -9.487
EBIT 1 -6.859 -8.777 -3.391 -5.259 -6.015 -9.631
Operating Margin -2,022.91% -2,362.69% -136.17% -194.99% -210.64% -313.63%
Earnings before Tax (EBT) 1 -7.795 -8.34 -3.433 -5.364 -6.025 -9.807
Net income 1 -7.795 -8.34 -3.433 -5.364 -6.025 -9.807
Net margin -2,298.91% -2,245.02% -137.85% -198.89% -210.98% -319.36%
EPS 2 -2.028 -1.512 -0.4012 -0.2872 -0.2400 -0.3600
Free Cash Flow 1 -5.093 -4.02 -2.619 -3.079 -3.005 -5.111
FCF margin -1,502.12% -1,082.23% -105.2% -114.18% -105.22% -166.43%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 2/28/18 3/29/19 3/31/20 2/25/21 2/24/22 2/27/23
1AUD in Million2AUD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - - - 0.16
Net Cash position 1 6.79 4.31 2.52 12.5 13.3 -
Leverage (Debt/EBITDA) - - - - - -0.0167 x
Free Cash Flow 1 -5.09 -4.02 -2.62 -3.08 -3 -5.11
ROE (net income / shareholders' equity) 203% -154% -100% -67.5% -46% -109%
ROA (Net income/ Total Assets) -109% -85.5% -42.1% -34.6% -26.6% -50%
Assets 1 7.179 9.752 8.147 15.5 22.62 19.62
Book Value Per Share 2 1.360 0.4800 0.2300 0.5200 0.4700 0.1700
Cash Flow per Share 2 1.350 0.5400 0.2700 0.5300 0.4800 0.1600
Capex 1 0.37 0.08 0.01 0.01 0.22 0.51
Capex / Sales 109.01% 22.49% 0.5% 0.29% 7.66% 16.52%
Announcement Date 2/28/18 3/29/19 3/31/20 2/25/21 2/24/22 2/27/23
1AUD in Million2AUD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Medical Diagnostic & Testing Equipment

1st Jan change Capi.
IMAGION BIOSYSTEMS LIMITED Stock Imagion Biosystems Limited
-79.15% 1.57M
SARTORIUS AG Stock Sartorius AG
-15.28% 18.56B
QUIDELORTHO CORPORATION Stock QuidelOrtho Corporation
-46.16% 2.71B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD. Stock Inner Mongolia Furui Medical Science Co., Ltd.
+17.00% 1.85B
SHANGHAI MICROPORT EP MEDTECH CO., LTD. Stock Shanghai MicroPort EP MedTech Co., Ltd.
-0.51% 1.66B
BIOTAGE AB Stock Biotage AB
+25.65% 1.22B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD. Stock Shanghai AoHua Photoelectricity Endoscope Co., Ltd.
-13.90% 989M
CONTEC MEDICAL SYSTEMS CO.,LTD Stock Contec Medical Systems Co.,Ltd
-21.76% 896M
VAREX IMAGING CORPORATION Stock Varex Imaging Corporation
-19.12% 660M
CELLAVISION AB Stock CellaVision AB
+6.37% 490M
Medical Diagnostic & Testing Equipment
  1. Stock Market
  2. Equities
  3. IBX Stock
  4. Financials Imagion Biosystems Limited